MedPath

Effect of Pioglitazone on proteinuria

Phase 2
Conditions
chronic renal failure.
chronic renal failure
Registration Number
IRCT138805222340N1
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
42
Inclusion Criteria

1. proteinuria (>500 mg/ day) for at least 6 months; 2. controlled blood pressure for at least 6 months; 3. age more than 18 years; 4. BMI less than 30; 5. serum creatinin less than 6 mg/dl; 6. no diabetes; 7. not using immunosuppressor agents; 8. no heart failure; 9. no liver disease. Exclusion criteria: 1. changes in doses of drugs which have effect on proteinuria (for example ACEI); 2. incidense of complications attributable to the drugs.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of proteinuria. Timepoint: Every 2 months. Method of measurement: collection of 24-hour urine protein.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath